Pennystocks.news — OTC, Nasdaq small cap and Canadian penny stock news

A Failed Phase 3 Drug Shows Signs of Life in Follow-On Data
Nasdaq 24 Sep · 19:00

A Failed Phase 3 Drug Shows Signs of Life in Follow-On Data

Fasedienol missed its Phase 3 goal in June. The open-label follow-on data looks more encouraging — but there was no placebo group to compare against.

Read the story →

Latest

How we work

Every article names the filing or release it came from. Read the source before acting on anything here.

Company in focus

Sponsored
Predictiv AI CSE:PAI FWB:7IT

Vertical AI software for logistics, healthcare and aviation.

The AI company working where the real money is made

The AI company working where the real money is made

See the full profile →

Predictiv AI has paid PennyStocks.News for this placement. It is advertising, not editorial coverage, and nothing here is investment advice.

Find them before we write about them.

Live screens — most active, gainers, losers and most volatile, US and Canada.
Open screener